IRVINE, Calif.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of glaucoma and other diseases of the eye, today announced the appointment of Deanne Melloy as Vice President of Marketing, reporting to Judith Robertson, Aerie’s Chief Commercial Officer. Aerie also announced the appointment of Norbert Lowe as Regional Sales Director for the
Category: Business
Hubble Contacts Closes Series A-III Financing to Support Global Growth
NEW YORK–(BUSINESS WIRE)–#Contacts–Subscription Contact Lens Brand Hubble Sets Sights on Canada and Beyond Following a $10MM Raise
Global Ophthalmics Partnering 2010-2017: Deal Trends, Players and Financials Analysis Report – Research and Markets
DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmics Partnering 2010-2017: Deal trends, players and financials” report has been added to Research and Markets’ offering. Global Ophthalmics Partnering 2010 to 2017 provides the full collection of Ophthalmics …
Glaukos Announces Participation in Wells Fargo Healthcare Conference
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, …
Glaukos Announces Participation in Wells Fargo Healthcare Conference
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, …
Iconic Therapeutics Appoints Brandon Smith Chief Operating Officer
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Iconic names COO.
Clinical Study Shows That Retinal Imaging May Detect Signs of Alzheimer’s Disease
SACRAMENTO, Calif.–(BUSINESS WIRE)–#Alzheimers–A new study provides the scientific basis for using noninvasive eye imaging to detect the pathological hallmarks of Alzheimer’s disease.
Hollywood Ophthalmologist Dr. Alan Mendelsohn Shares Precautions for Viewing the Eclipse
HOLLYWOOD, Fla.–(BUSINESS WIRE)–#eclipse–In anticipation of the upcoming eclipse on August 21, South Florida Ophthalmologist Dr. Alan Mendelsohn has a warning for the public.
LASIK Surgery Market – Forecasts and Opportunity Assessment by Technavio
LONDON–(BUSINESS WIRE)–#LASIKsurgery–According to the latest market study released by Technavio, the global LASIK surgery market is expected to grow at a CAGR of almost 6% until 2021.
Ophthotech Announces Results from Third Phase 3 Trial of Fovista® in Wet Age-Related Macular Degeneration
NEW YORK–(BUSINESS WIRE)–Ophthotech today announced that the pre-specified primary endpoint of mean change in visual acuity at 12 months was not achieved.
Aerie Pharmaceuticals Announces Appointment of Isabel Moredo, PharmD, as Eastern Regional Director of Medical Science Liaisons
IRVINE, Calif.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of glaucoma and other diseases of the eye, today announced the appointment of Isabel Moredo, PharmD, as Eastern Regional Director of Medical Science Liaisons, reporting to Welyn Bui, PharmD, Aerie’s National Director of Medical Affairs. Dr. Moredo will be responsible for leadi
NovaBay Pharmaceuticals Reports Second Quarter 2017 Financial Results
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova® for lid and lash hygiene in the domestic eye care market, reports financial results for the three and six months ended June 30, 2017 and provides a business update. “We had record Avenova unit volume through the pharmacy channel during the second quarter, along with an 80% increase in revenue through this channel over the prior year.
Allegro Ophthalmics Announces Positive Topline Results from DEL MAR Phase 2b Stage 2 Trial Evaluating Luminate® in Patients with Diabetic Macular Edema
SAN JUAN CAPISTRANO, Calif.–(BUSINESS WIRE)–#DELMARstudy–Allegro Ophthalmics announced that the DEL MAR Phase 2b Stage 2 clinical trial evaluating Luminate in patients with DME met its primary endpoint.
Optovue First in US to Receive FDA Clearance for Corneal Epithelial Thickness Mapping
FREMONT, Calif.–(BUSINESS WIRE)–Optovue is the first in the US to receive FDA clearance for corneal epithelial thickness mapping.
Aerpio Pharmaceuticals Commences Trading on the OTCQB® Market
CINCINNATI–(BUSINESS WIRE)–Aerpio Pharmaceuticals, Inc. (OTCQB:ARPO), a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases, announced today that shares of the Company’s common stock have been cleared for trading on the OTC Market Group’s OTCQB® Market (“OTCQB”) in the United States. Shares of Aerpio’s common stock will trade under the ticker symbol “ARPO”, effective at the market open on August 8, 2017. In March 2017, Aerpio raised approximately $40 m
John Theurer Cancer Center and MedStar Georgetown University Hospital Announce 100th Blood Stem Cell Transplant
WASHINGTON & HACKENSACK, N.J.–(BUSINESS WIRE)–John Theurer Cancer Center and MedStar Georgetown University Hospital Announce 100th Blood Stem Cell Transplant
Glaukos Corporation Announces Second Quarter 2017 Financial Results
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, …
Age-Related Macular Degeneration Therapeutics Pipeline Analysis, 2017 – Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments – Research and Markets
DUBLIN–(BUSINESS WIRE)–The “Age-Related Macular Degeneration Therapeutics Pipeline Analysis, 2017 – Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments” report has been added to Research and Markets’ offering. The global age-related macular degeneration market accounted for revenue of $5,335.7 million in 2015, and it is expected to grow at a CAGR of 7.6% during 2016 – 2022. Among the various types, the wet AMD segment is expected to witness the faster gro
MellingMedical Granted Pharmaceutical Distribution License
ALEXANDRIA, Va.–(BUSINESS WIRE)–#healthcare–MellingMedical, a CVE-Verified Service Disabled Veteran-Owned Small Business, was recently licensed as a pharmaceutical wholesale distributor.
Aerie Pharmaceuticals to Present at the Canaccord Genuity Growth Conference
IRVINE, Calif.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (Nasdaq:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of glaucoma and other diseases…